Cigna Corporation (CI) & Its Rivals Financial Contrast
Cigna Corporation (NYSE: CI) is one of 14 publicly-traded companies in the “Managed Health Care” industry, but how does it contrast to its competitors? We will compare Cigna Corporation to related businesses based on the strength of its institutional ownership, analyst recommendations, dividends, profitability, valuation, earnings and risk.
This is a summary of current recommendations and price targets for Cigna Corporation and its competitors, as provided by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|Cigna Corporation Competitors||79||872||1430||22||2.58|
Cigna Corporation presently has a consensus target price of $192.00, suggesting a potential upside of 2.56%. As a group, “Managed Health Care” companies have a potential upside of 1.45%. Given Cigna Corporation’s stronger consensus rating and higher probable upside, analysts clearly believe Cigna Corporation is more favorable than its competitors.
This table compares Cigna Corporation and its competitors’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|Cigna Corporation Competitors||1.70%||10.53%||3.41%|
Risk and Volatility
Cigna Corporation has a beta of 0.43, indicating that its share price is 57% less volatile than the S&P 500. Comparatively, Cigna Corporation’s competitors have a beta of 0.76, indicating that their average share price is 24% less volatile than the S&P 500.
Insider & Institutional Ownership
88.0% of Cigna Corporation shares are owned by institutional investors. Comparatively, 90.2% of shares of all “Managed Health Care” companies are owned by institutional investors. 1.3% of Cigna Corporation shares are owned by insiders. Comparatively, 2.5% of shares of all “Managed Health Care” companies are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.
Valuation & Earnings
This table compares Cigna Corporation and its competitors gross revenue, earnings per share (EPS) and valuation.
|Gross Revenue||EBITDA||Price/Earnings Ratio|
|Cigna Corporation||$40.53 billion||$4.21 billion||21.57|
|Cigna Corporation Competitors||$52.30 billion||$3.74 billion||17.70|
Cigna Corporation’s competitors have higher revenue, but lower earnings than Cigna Corporation. Cigna Corporation is trading at a higher price-to-earnings ratio than its competitors, indicating that it is currently more expensive than other companies in its industry.
Cigna Corporation pays an annual dividend of $0.04 per share and has a dividend yield of 0.0%. Cigna Corporation pays out 0.5% of its earnings in the form of a dividend. As a group, “Managed Health Care” companies pay a dividend yield of 1.0% and pay out 21.2% of their earnings in the form of a dividend.
Cigna Corporation beats its competitors on 9 of the 15 factors compared.
About Cigna Corporation
Cigna Corporation (Cigna), together with its subsidiaries, is a health services company. The Company offers medical, dental, disability, life and accident insurance and related products and services. The Company’s segments include Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations and Corporate. Its Global Health Care segment aggregates the commercial and Government operating segments. Its commercial operating segment encompasses the United States commercial and certain international healthcare businesses serving employers and their employees, other groups, and individuals. Its Global Supplemental Benefits segment offers supplemental health, life and accident insurance products in selected international markets and in the United States. Its Group Disability and Life segment provides group long-term and short-term disability insurance, group life insurance, accident and specialty insurance and related services.
Receive News & Stock Ratings for Cigna Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Corporation and related stocks with our FREE daily email newsletter.